Filing Details

Accession Number:
0001127602-12-015851
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-03 19:43:36
Reporting Period:
2012-05-01
Filing Date:
2012-05-03
Accepted Time:
2012-05-03 19:43:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318154 Amgen Inc AMGN Biological Products, (No Disgnostic Substances) (2836) 953540776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1199306 Anna Richo One Amgen Center Drive
Thousand Oaks CA 91320-1799
Svp & Cco No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-01 2,950 $42.13 39,431 No 4 M Direct
Common Stock Disposition 2012-05-01 2,309 $71.11 37,122 No 4 F Direct
Common Stock Disposition 2012-05-01 641 $0.00 36,481 No 5 G Direct
Common Stock Acquisiton 2012-05-01 641 $0.00 10,256 No 5 G Indirect The Nicholas A. Moore and Anna S. Richo Family Trust
Common Stock Acquisiton 2012-05-01 10,000 $50.44 46,481 No 4 M Direct
Common Stock Acquisiton 2012-05-01 10,000 $58.43 56,481 No 4 M Direct
Common Stock Disposition 2012-05-01 10,000 $70.76 46,481 No 4 S Direct
Common Stock Disposition 2012-05-01 10,000 $70.80 36,481 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 5 G Direct
No 5 G Indirect The Nicholas A. Moore and Anna S. Richo Family Trust
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nqso (Right to Buy) Disposition 2012-05-01 2,950 $0.00 2,950 $42.13
Common Stock Nqso (Right to Buy) Disposition 2012-05-01 10,000 $0.00 10,000 $50.44
Common Stock Nqso (Right to Buy) Disposition 2012-05-01 10,000 $0.00 10,000 $58.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-04-29 2015-04-29 No 4 M Direct
10,000 2010-04-28 2016-04-28 No 4 M Direct
20,000 2011-04-26 2020-04-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,319 Indirect 401(k) Plan
Footnotes
  1. These shares are being transferred to the reporting person's Family Trust.
  2. The price reported is an average price. The prices ranged from $70.73 to $70.78 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
  3. The price reported is also an average price. The prices ranged from $70.71 to $70.89 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
  4. These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 20,000 RSUs which fully vest on 10/28/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  5. These shares include 1,306 shares of common stock acquired under the Company's Employee Stock Purchase Plan.
  6. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.